Hematology
David Miklos, M.D., PH. D.
James and Katherine Lau Professor
Stanford, CA
David Miklos, M.D., Ph.D., is Chief of the Stanford Blood and Marrow Transplant (BMT) and Cell Therapy Program, overseeing 750 cancer cell therapies annually, with a subspecialty focus in hematology-oncology emphasizing allogeneic hematopoietic cell transplantation (alloHCT), CAR-T cell therapies, and management of graft-versus-host disease (GVHD). He treats patients with blood cancers including leukemia, lymphoma, multiple myeloma, as well as anemia, aplastic anemia, hemophilia, and thrombosis,
30+
Years in Practice
Credentials
Board Certifications
- American Board of Internal Medicine, Hematology (2019)
Education & Training
- M.D., Ph.D. in Genetics, Yale University (1995)
- B.S., University of Notre Dame (1987)
- Internship: Brigham and Women's Hospital Harvard Medical School (1996)
- Residency: Brigham and Women's Hospital Harvard Medical School (1998)
- Fellowship: Dana Farber Cancer Institute Hematology Oncology Fellowship (2001)
Recognition & Leadership
Awards & Honors
- Phi Betta Kappa, University of Notre Dame (1987)
- Alpha Omega Alpha, Yale Medical School (1995)
- Predoctoral Fellow, Howard Hughes Medical Institute (1989-1993)
- Medical Scientist Training Fellow, NIH (1993-1995)
- Clinical Investigator Training Program Scholar, Harvard Medical School (2001-2003)
Leadership Roles
- Chief, BMT and Cell Therapy Program, Stanford University
Clinical Focus
Subspecialties
Hematology & Oncology
Conditions & Treatments
LymphomaChronic Lymphocytic LeukemiaLeukemiaCAR-T Cell TherapyStem Cell TransplantGraft-versus-Host DiseaseAplastic Anemia
Practice Details
Hospital Affiliations
- Stanford University Medical Center
- Stanford Health Care
- Pelvic Health Center, Stanford University School of Medicine
Languages
English
Experience
30+ years in practice